Perioperative management in chronically anticoagulated children undergoing tonsillectomy
Pediatrics International · 2023
DOI: 10.1111/ped.15438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, 2023. Verfasst von Inbal Hazkani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Otolaryngology-Head and Neck Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Tonsillectomy, Thromboembolism. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
When undergoing tonsillectomy, patients at high risk of thrombosis who require chronic anticoagulation therapy pose a special challenge as bleeding may occur up to 2 weeks after surgery. Because of a lack of evidence‐based data, there is no consensus on the best management for such patients. The objective of our study was to review perioperative anticoagulation bridging strategies in children undergoing tonsillectomy.
Methods
The study group were a retrospective series of patients on chronic anticoagulation therapy at high risk of a thromboembolic event, who underwent tonsillectomy from 2010 to 2021. Patients whose anticoagulation treatment was discontinued because of a low risk of thromboembolic events were excluded.
Results
Four patients met the inclusion criteria (age range, 1.5–16.1 years). All patients were admitted prior to surgery for bridging therapy with intravenous unfractionated heparin (UFH), drip‐titrated to a therapeutic dose until 4–6 h prior to surgery. The estimated blood loss during surgery was minimal in all surgeries. Unfractionated heparin was readministered according to the hospital protocol on the night of surgery and titrated to a therapeutic dose. Warfarin was restarted within 2 days postsurgery for all patients. High‐risk patients were kept in hospital until postoperative day 6–8 because of concern for delayed bleeding. One patient was noticed to have blood‐tinged sputum requiring no intervention; none of the patients developed early or delayed hematemesis.
Conclusions
Our data show that bridging therapy with UFH has been successful in chronically anticoagulated patients undergoing tonsillectomy. These patients require multidisciplinary care for the management of their pre‐ and postoperative course.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Otolaryngology-Head and Neck Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Division of Hematology, Oncology, and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
ORCID-Profile: Inbal Hazkani
Zitieren
APA
Hazkani, I., Billings, K. R., Edwards, E., Stein, E., Bhat, R., & Lavin, J. (2023). Perioperative management in chronically anticoagulated children undergoing tonsillectomy. Pediatrics International. https://doi.org/10.1111/ped.15438
Vancouver
Hazkani I, Billings KR, Edwards E, Stein E, Bhat R, Lavin J. Perioperative management in chronically anticoagulated children undergoing tonsillectomy. Pediatrics International. 2023. doi:10.1111/ped.15438
BibTeX
@article{Hazkani2023,
author = {Hazkani, Inbal and Billings, Kathleen R and Edwards, Evan and Stein, Eli and Bhat, Rukhmi and Lavin, Jennifer},
title = {Perioperative management in chronically anticoagulated children undergoing tonsillectomy},
journal = {Pediatrics International},
year = {2023},
doi = {10.1111/ped.15438}
}
EUVIMED